Bernard Prudhon

1.0k citations

15 papers · 618 indexed · h-index 12

Impact in

Cell Biology top 5%
- Cellular transport and secretion
- Microtubule and mitosis dynamics
Cellular and Molecular Neuroscience top 10%
- Genetic Neurodegenerative Diseases
- Hereditary Neurological Disorders

Papers in

Cell Biology 11
- Cellular transport and secretion 11
- Microtubule and mitosis dynamics 4
Cellular and Molecular Neuroscience 5
- Genetic Neurodegenerative Diseases 4
- Hereditary Neurological Disorders 2

Co-authors: Marc Bitoun Pascale Guicheney Anne‐Cécile Durieux Stéphane Vassilopoulos Jorge A. Bevilacqua Norma B. Romero Jeanne Lainé Maud Beuvin
Journals: Molecular Therapy — Nucleic Acids (4 papers)Human Mutation (1 paper)Scientific Reports (1 paper)Current Gene Therapy (1 paper)Traffic (1 paper)
Partner nations: France Chile Argentina

In The Last Decade

Bernard Prudhon

15 papers receiving 612 citations

Peers

Countries citing papers authored by Bernard Prudhon

Since Specialization

Citations

This map shows the geographic impact of Bernard Prudhon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernard Prudhon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernard Prudhon more than expected).

Fields of papers citing papers by Bernard Prudhon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernard Prudhon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernard Prudhon. The network helps show where Bernard Prudhon may publish in the future.

Co-authors

The 25 scholars most cited alongside Bernard Prudhon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Bernard Prudhon Line = papers co-authored together Bernard Prudhon links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work
1	Benefits of therapy by dynamin-2-mutant-specific silencing are maintained with time in a mouse model of dominant centronuclear myopathy Molecular Therapy — Nucleic Acids ·Delphine Trochet, Bernard Prudhon, Mehdi Fazel, А. Е. Романов, Maud Beuvin, Laura Julien, Sofia Benkhelifa‐Ziyyat, Mai Thao Bui, Norma B. Romero, Marc Bitoun	2022	2
2	Development of versatile allele-specific siRNAs able to silence all the dominant dynamin 2 mutations Molecular Therapy — Nucleic Acids ·JD. Wilkinson, Mehdi Fazel, Bernard Prudhon, Heloiza Anacleto Virginio, Bruno Cadot, Kamel Mamchaoui, Delphine Trochet, Marc Bitoun	2022	6
3	Nuclear defects in skeletal muscle from a Dynamin 2-linked centronuclear myopathy mouse model Scientific Reports ·G Aveta, Sestina Falcone, Jeanne Lainé, Bernard Prudhon, 藤巻宏, Marc Bitoun	2019	15
4	Gene Therapy via Trans-Splicing for LMNA-Related Congenital Muscular Dystrophy Molecular Therapy — Nucleic Acids ·Fériel Azibani, Astrid Brull, Ludovic Arandel, Maud Beuvin, Isabelle Nelson, Arnaud Jollet, 易国勤, Bernard Prudhon, Sofia Benkhelifa‐Ziyyat, Marc Bitoun, Stéphanie Lorain, Gisèle Bonne, A. Bertrand	2017	32
5	Allele‐specific silencing therapy for Dynamin 2‐related dominant centronuclear myopathy EMBO Molecular Medicine ·Delphine Trochet, Bernard Prudhon, Maud Beuvin, Cécile Peccate, Stéphanie Lorain, Laura Julien, Sofia Benkhelifa‐Ziyyat, Aniko Nemet, Kamel Mamchaoui, Arnaud Ferry, Jocelyn Laporte, Pascale Guicheney, Stéphane Vassilopoulos, Marc Bitoun	2017	43
6	Reprogramming the Dynamin 2 mRNA by Spliceosome-mediated RNA Trans-splicing Molecular Therapy — Nucleic Acids ·Delphine Trochet, Bernard Prudhon, Arnaud Jollet, Stéphanie Lorain, Marc Bitoun	2016	10
7	Therapy for Dominant Inherited Diseases by Allele-Specific RNA Interference: Successes and Pitfalls Current Gene Therapy ·Delphine Trochet, Bernard Prudhon, Stéphane Vassilopoulos, Marc Bitoun	2015	23
8	A Centronuclear Myopathy – Dynamin 2 Mutation Impairs Autophagy in Mice Traffic ·Anne‐Cécile Durieux, Stéphane Vassilopoulos, Jeanne Lainé, B. Fraysse, Laura Briñas, Bernard Prudhon, Josiane Castells, M Suhaib Riaz, Gisèle Bonne, Pascale Guicheney, Marc Bitoun	2012	44
9	Dynamin 2 and human diseases Journal of Molecular Medicine ·Anne‐Cécile Durieux, Bernard Prudhon, Pascale Guicheney, Marc Bitoun	2010	98
10	A centronuclear myopathy-dynamin 2 mutation impairs skeletal muscle structure and function in mice Human Molecular Genetics ·Anne‐Cécile Durieux, Alban Vignaud, Bernard Prudhon, William Miceli Kumar, Maud Beuvin, Stéphane Vassilopoulos, B. Fraysse, Arnaud Ferry, Jeanne Lainé, Norma B. Romero, Pascale Guicheney, Marc Bitoun	2010	91
11	Dynamin 2 mutations associated with human diseases impair clathrin-mediated receptor endocytosis Human Mutation ·Marc Bitoun, Anne‐Cécile Durieux, Bernard Prudhon, Jorge A. Bevilacqua, Adrien Herlédan, Vehary Sakanyan, Andoni Urtizberea, Luis Cartier, Norma B. Romero, Pascale Guicheney	2009	67
12	A NEW CENTRONUCLEAR MYOPATHY PHENOTYPE DUE TO A NOVEL DYNAMIN 2 MUTATION Neurology ·Marc Bitoun, Jorge A. Bevilacqua, B. Eymard, Bernard Prudhon, M Fardeau, Pascale Guicheney, Norma B. Romero	2009	28
13	A novel mutation in the dynamin 2 gene in a Charcot-Marie-Tooth type 2 patient: Clinical and pathological findings Neuromuscular Disorders ·Marc Bitoun, Tanya Stojkovic, Bernard Prudhon, Claude‐Alain Maurage, Philippe Latour, Patrick Vermersch, Pascale Guicheney	2008	37
14	Dynamin 2 mutations cause sporadic centronuclear myopathy with neonatal onset Annals of Neurology ·Marc Bitoun, Jorge A. Bevilacqua, Bernard Prudhon, Svetlana Maugenre, Ana Lía Taratuto, Soledad Monges, Fabiana Lubieniecki, Claude Cancès, Emmanuelle Uro‐Coste, M. Mayer, Michel Fardeau, Jakob Ribič, Pascale Guicheney	2007	104
15	Administration of insulin?like growth factor?1 (IGF?1) improves both structure and function of delta?sarcoglycan deficient cardiac muscle in the hamster Basic Research in Cardiology ·ЛА Маслій, Bernard Prudhon, عصام أبو الیزید محمد عبد الله عبد الله, Huda Hamdy Mohammed, Marc Fiszman, Yves Fromes	2004	18

About Bernard Prudhon

Bernard Prudhon is a scholar working on Cell Biology, Cellular and Molecular Neuroscience, Molecular Biology, Biotechnology and Endocrinology, Diabetes and Metabolism, having authored 15 papers that have together received 618 indexed citations. Recurring topics across this work include Cellular transport and secretion (11 papers), Nuclear Structure and Function (6 papers), Muscle Physiology and Disorders (4 papers), Microtubule and mitosis dynamics (4 papers), Genetic Neurodegenerative Diseases (4 papers), RNA regulation and disease (2 papers), Hereditary Neurological Disorders (2 papers) and Pancreatic function and diabetes (1 paper). The work is most often cited by research in Cell Biology (334 citations), Cellular and Molecular Neuroscience (207 citations), Molecular Biology (421 citations), Genetics (60 citations) and Cardiology and Cardiovascular Medicine (126 citations). Bernard Prudhon has collaborated with scholars based in France, Chile and Argentina. Frequent co-authors include Marc Bitoun, Pascale Guicheney, Anne‐Cécile Durieux, Stéphane Vassilopoulos, Jorge A. Bevilacqua, Norma B. Romero, Jeanne Lainé, Maud Beuvin, Delphine Trochet and B. Fraysse. Their work appears in journals such as Molecular Therapy — Nucleic Acids, Human Mutation, Scientific Reports, Current Gene Therapy and Traffic.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact